(Reuters) -Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s presence in respiratory treatments as it readies for the patent expiry of its blockbuster cancer drug.
(Reporting by Christy Santhosh in Bengaluru; Editing by Sriraj Kalluvila)
